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Background: Siwu decoction categorized formulae (SWDCF) are widely used for treating gynecological diseases.
This study aims to elucidate the differences of bioactive constituents in SWDCF by ultra-high performance liquid
chromatography coupled with time-of-flight mass spectrometry (UPLC - QTOF - MS /MS) and HPLC-DAD.
Methods: An efficient method based on UPLC - QTOF - MS /MS was developed for identifying the chemical
profiles of SWDCF. HPLC-DAD method was used for quantifying seven chemical markers in SWDCF.
Results: Eighty four components were identified or characterized, including ten organic acids, thirty glycosides
(monoterpene or iridoid or phenylpropanoids glycosides), fourteen lactones, eighteen flavonoids, and eleven
alkaloids in the complex system. The datasets of tR-m/z pairs, ion intensities and sample codes were processed with
supervised orthogonal partial least squared discriminant analysis to compare these decoction samples. After a clear
classification was established, OPLS-DA was performed and 16 common components with relative quantity in
SWDCF samples were determined. Gallic acid, protocatechuic acid, vanillic acid, caffeic acid, paeoniflorin, ferulic
acid, and senkyunolide I were selected as the chemical markers to identify SWDCF by HPLC-DAD.
Conclusion: The chemical profiles with 84 components in SWDCF, including monoterpene glycosides, acetophenones,
galloyl glucoses, even some isomers in the complex system were characterized by UPLC–QTOF–MS/MS.Background
Chinese medicine (CM) is holistically formulated for treating
complicated CM syndromes (“ZHENG” in Chinese) [1]. The
researches on categorized formulae (CF) based on a basic
formula composition may help understand the rules of
formulation and Fang-Zheng consistency in CM [2].
Siwu decoction (SWD) is a classical prescription that is
widely used for the treatment of women’s diseases in CM,
such as relief of emmeniopathy, climacteric syndrome,
dysmenorrhea and other estrogen-related diseases [3]. A
recent study demonstrated that the SWD can be synergis-
tically used with Western medicine [4]. SWD consists of
four herbs, i.e., Angelicae sinensis Radix, Chuanxiong
Rhizoma, Paeoniae Radix Alba, and Rehmanniae Radix* Correspondence: duanja@163.com
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reproduction in any medium, provided the or[5]. A series of SWD-based formulae used to treat women’s
diseases especially for primary dysmenorrheal (PD) are
considered as Siwu decoction categorized formulae
(SWDCF), including Taohong Siwu decoction (THSWD),
Xiangfu Siwu decoction (XFSWD), Shaofu Zhuyu decoc-
tion (SFZYD), and Qinlian Siwu decoction (QLSWD). The
compositions and applications of SWDCF were described
in Table 1. These formulae are usually adopted to treat
different symptoms of different kinds of PD.
Our recent studies [6,7] showed that SWDCF inhibited
uterine contraction and had analgesic effects on primary
dysmenorrhea model mice. Their anti-inflammatory acti-
vities, hemorheological improvement and ovarian regula-
tion in rats with blood stasis were elucidated [8,9].
Moreover, SWDCF inhibited COX-2 enzyme and platelet
aggregation in vitro [9,10]. The main constituents of
SWDCF belong to several natural product groups, such as
phenolic acids, phthalides, alkaloids, terpene glycosides,This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 The composition and application of SWDCF
Prescriptions Composition Application
Siwu decoction (SWD) (Angelica sinensis) Angelicae sinensis Radix 9 g, (Ligustium chuanxiong)
Chuanxiong Rhizoma 9 g, (Paeonia lactiflora) Paeoniae Radix Alba 9 g,
and (Rehmannia glutinosa) Rehmanniae Radix 9 g
Cure women’ diseases, such
as dysmenorrhea and other
estrogen related diseases
Taohong-Siwu decoction (THSWD) (Angelica sinensis) Angelicae sinensis Radix 9 g, (Ligustium chuanxiong)
Chuanxiong Rhizoma 9 g, (Paeonia lactiflora) Paeoniae Radix Alba 9 g,
(Rehmannia glutinosa) Rehmanniae Radix 9 g, (Prunus persica) Persicae
Semen 9 g, and (Carthamus tinctorius) Carthami Flos 6 g
Cure PD with syndrome of
deficiency of blood.
Xiangfu-Siwu decoction (XFSWD) (Angelica sinensis) Angelicae sinensis Radix 9 g, (Ligustium chuanxiong)
Chuanxiong Rhizoma 4.5 g, (Paeonia lactiflora) Paeoniae Radix Alba 4.5 g,
(Rehmannia glutinosa) Rehmanniae Radix 12 g, (Cyperus rotundus) Cyperi
Rhizoma, 4.5 g, (Corydalis yanhusuo) Corydalis Rhizoma 4.5 g, and
(Aucklandia lappa) Aucklandiae Radix 3 g
Cure PD induced by
stagnation of the circulation
of vital energy
Shaofu-Zhuyu decoction (SFZYD) (Angelica sinensis) Angelicae sinensis Radix 9 g, (Ligustium chuanxiong)
Chuanxiong Rhizoma 3 g, (Corydalis yanhusuo)Corydalis Rhizoma 3 g,
(Paeonia veitchii) Paeoniae Radix Rubra 6 g, (Cinnamomum cassia)
Cinnamomi Cortex 3 g, (Foeniculum vulgare) Foeniculi Fructus 1.5 g,
(Zingiber officinale) Zingiberis Rhizoma 3 g, (Commiphora myrrha) Myrrha
3 g, (Trogopterprus xanthipes) Trogopterpri Faeces 6 g, and (Typha
angustifolia) Typhae Pollen 9 g
Cure PD with syndrome of
cold coagulation and blood
stasis
Qinlian-Siwu decoction (QLSWD) (Angelica sinensis) Angelicae sinensis Radix 9 g, (Ligustium chuanxiong)
Chuanxiong Rhizoma 9 g, (Paeonia lactiflora) Paeoniae Radix Alba 9 g,
and (Rehmannia glutinosa) Rehmanniae Radix 9 g, (Scutellaria baicalensis)
Scutellariae Radix 4.5 g and (Coptis chinensis) Coptidis Rhizoma 4.5 g
Cure PD resulted from
pathogenic heat or
inflammation
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report on the constituent profiles of SWDCF is available.
The investigations of the components of SWDCF are
important to reveal their effects and action mechanisms.
However, the complicated chemical profiles of SWDCF
components demand a rapid and efficient method for
chemical profiling of SWDCF.
This study aims to profile the constituents of SWDCF
by UPLC-QTOF-MS/MS with MarkerLynx analysis and
identify SWDCF with several chemical markers.Figure 1 Chemical structures of the quantitative compounds in the SMethods
Chemicals, reagents and materials
Gallic acid, protocatechuic acid, vanillic acid, caffeic acid,
paeoniflorin, ferulic acid, and senkyunolide I (Figure 1)
were purchased from National Institute for the Control of
Pharmaceutical and Biological products (China).
Acetonitrile was HPLC-grade from Merck (Darmstadt,
Germany) and deionized water was purified by a Millipore
water purification system (Millipore, Milford, MA, USA)
and filtered with 0.22 μm membranes. Other reagentiwu decoction categorized formulae.
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Reagent Co., Ltd., Shanghai, China).
Herbal medicines of Angelicae sinensis Radix,Chuanxiong
Rhizoma, Paeoniae Radix Alba, Rehmanniae Radix, Persicae
Semen, Carthami Flos, Cyperi Rhizoma, Aucklandiae Radix,
Corydalis Rhizoma, Paeoniae Radix Rubra, Cinnamomi
Cortex, Foeniculi Fructus, Zingiberis Rhizoma, Myrrha,
Trogopterpri Faeces, Typhae Pollen, Scutellariae Radix and
Coptidis Rhizoma,were purchased from the following towns
(provinces):Minxian (Gansu), Pengzhou (Sichuan),Tongling
(Anhui), Huaiqing (Hehan), Anguo (Hebei), Tacheng
(Xinjiang), Linyi (Shandong), Lijiang (Yunnan), Songyang
(Zhejiang), Chifeng (Neimeng), Yulin (Guangsi), Wuwei
(Gansu), Yulin (Guangsi), Guangdong, Changzhi (Shanxi),
Yixing (Jiangsu), Chengde (Hebei), and Mianyang (Sichuan),
respectively. All crude herbs were identified by the Prof.
Jin-ao Duan in accordance with the Pharmacopoeia of
People’s Republic of China [14]. The voucher specimens (no.
NJUTCM-20101112-20101129) were deposited in Jiangsu
Key Laboratory for TCM Formulae Research, Nanjing Uni-
versity of ChineseMedicine.Apparatus and chromatographic conditions
UPLC-QTOF-MS/MS qualitative analysis
Chromatography was performed on an AcQuity™ UPLC
system with a conditioned autosampler (Waters Corp.,
Milford, MA, USA) at 4°C. The separation was carried out
on an AcQuity UPLCTM BEH C18 column (100 mm×
2.1 mm i.d., 1.7 μm; Waters Corp., Milford, MA, USA)
maintained at 35°C. The mobile phase consisted of 0.1%
formic acid (HCOOH) in water as solvent A and aceto-
nitrile (ACN) as solvent B. The gradient conditions of the
mobile phase were: 0 min 95% A, 9.0 min 56% A,
12.0 min 26% A, 20.0 min 10% A, 22.0 min 10% A,
25.0 min 95% A. The flow rate was 0.40 mL/min. The
sample injection volume was 5 μL.
Mass spectrometric detection was carried out on an
AcQuity Synapt Mass Spectrometer equipped with an
electrospray ionization (ESI) interface (Waters, Milford,
MA, USA). High purity nitrogen was used as the nebulizer
and auxiliary gas; argon was utilized as the collision gas.
The ESI source was operated in positive and negative
ionization mode with a capillary voltage of 3 kV, sampling
cone voltage of 10 V, cone gas flow of 50 L/h, desolvation gas
flow of 700 L/h, desolvation temperature of 350°C, source
temperature of 120°C, collision energy of 45 V, and the full
scan spectra from 100 to 1000 Da. Leucine-enkephalin was
used as the lock mass generating an [M+H]+ ion (m/z
556.2771) and [M-H]- ion (m/z 554.2615) at a concentration
of 200 pg/mL and flow rate of 100 μL/min. Data acquisition
and processing were performed by MassLynx 4.1 and
MarkerLynx 4.1 (Waters Corp., Milford, MA, USA) for peak
detection.HPLC-PDA quantificative analysis
The quantification analysis was performed on a Waters-
2695 Alliance HPLC (Waters Corporation, Milford, MA,
USA) equipped with an on-line degasser, an auto-sampler
and a 2996 photodiode array detector. UV detection was
achieved at 210–400 nm. A Waters Sun Fire™ C18 column
(4.6 × 250 mm, 5 μm, serial no. 186002560 Waters Corpo-
ration, USA) was used. A linear gradient elution of A
CH3OH and B (CH3COOH: H2O = 0.1: 100) was used.
The gradient program is 85% B in 0–8 min, 85-80% B in
8–10 min, 80-74% B in 10–30 min, 74-66% B in 30–
40 min, 66-34% B in 40–60 min, 34-10% B in 60–85 min.
The solvent flow rate was 1 mL/min and the column
temperature was set at 30°C. Re-equilibration duration was
15 min between individual runs. A Waters 2996 photo
diode array was connected to the liquid chromatography
for detection of the raw data.
Preparation of standard solutions
A mixed standard stock solution containing gallic acid
(1), protocatechuic acid (2), vanillic acid (3), caffeic acid
(4), paeoniflorin (5), ferulic acid (6), and senkyunolide I
(7) was prepared in methanol. The working standard
solutions were prepared by diluting the mixed standard
solution with methanol to a series of proper concen-
trations within the ranges: 1, 148–1480.0 μg/mL; 2, 38.40–
384.00 μg/mL; 3, 32.0-320.0 μg/mL; 4, 35.6-356.0 μg/mL; 5,
476.0-4760.0 μg/mL; 6, 136.0-1360.0 μg/mL; 7, 46.0-
460.0 μg/mL. The standard stock and working solutions
were all stored at 4°C and filtered through a 0.22 μm mem-
brane prior to injection.
Preparation of sample solutions
The mixtures of SWDCF (Table 1) were crushed into
small pieces and refluxed with 10 times water for 2 h
twice. The filtrates from each decoction were combined
and concentrated to 1.0 mg/mL at 70°C. The filtrates
were added 95% ethanol until the concentration of etha-
nol was adjusted to 50%. After centrifugation at 3000 × g
for 10 min, the supernatant was stored at 4°C and
filtered through a 0.22 μm membrane filter before the
UPLC-QTOF-MS analysis and the HPLC-DAD analysis.
Validation of the HPLC method
Calibration curves, limits of detection and quantification
The working standard solutions with at least six differ-
ent concentrations (1, 148–1480.0 μg/mL; 2, 38.40-
384.00 μg/mL; 3, 32.0-320.0 μg/mL; 4, 35.6-356.0 μg/mL;
5, 476.0-4760.0 μg/mL; 6, 136.0-1360.0 μg/mL; 7, 46.0-
460.0 μg/mL) were analyzed, and the calibration curves
were calculated by linear regression of the double logarith-
mic plots of the peak area versus the concentration of the
reference solution injected. The limits of detection and
quantification (LODs and LOQs) under the present
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by diluting the standard solution when the signal-to-noise
ratios (S/N) of analytes were about 3 and 10, respectively.
The S/N was calculated as the peak height divided by the
background noise value.
Precision, repeatability and accuracy
The intra-day and inter-day variations, which were chosen to
determine the precision of the developed method, were
investigated by determining the seven analytes in six
replicates during a single day and by duplicating the
experiments on three consecutive days. Variations of the
peak area were taken as the measures of precision and
expressed as relative standard deviations (R.S.D.).
Repeatability was confirmed with six independent ana-
lytical sample solutions prepared according to the
methods describing before and expressed by R.S.D. These
SWTCF sample solutions was stored at 4°C, and injected
into the HPLC apparatus at 0, 2, 4, 8, and 12 hr, respect-
ively, to evaluate the stability of the solution.
Recovery test was performed by adding accurate amounts
of the seven standards into a certain amounts separately to
evaluate the accuracy of this method. The spiked samples
were then extracted, processed, and quantified in accord-
ance with the methods mentioned above. Six replicates
were performed for the test. The average recovery percent-
age was calculated by the formula: recovery (%) = (observed
amount − original amount)/spiked amount × 100%.
MarkerLynx™ analysis
The data obtained from positive and negative ion mode
of all determined samples were analyzed by MarkerLynx
v4.1 software (Waters, Manchester, UK) with the help of
multivariate statistical analysis, to reveal any potential
changed components in SWDCF. The original data were
processed using the following parameters: initial reten-
tion time of 0 min, final retention time of 25 min, and
mass in the range 100–1000 Da, with a mass tolerance
of 0.02 Da, mass window of 0.02 Da, retention time win-
dow of 0.1 min, noise elimination level 6. For peak inte-
gration, peak width at 5% of the height was 1 s, peak-to
-peak baseline noise was automatically calculated, and
peak intensity threshold was 10. No specific mass or ad-
duct was excluded. Isotopic peaks were excluded for
analysis. For data analysis, a list of the intensities of the
peaks detected was generated using tR and mass data
(m/z) pairs as the identifier of each peak. An ID was
assigned to each of these tR-m/z pairs in the order of
their UPLC elution for data alignment [15]. The process
was repeated for each run. After completion, the correct
peak intensity data for each tR-m/z pair of the entire
batch of samples were aligned in the final data table.
The ions that showed the same tR (with a tolerance of
0.1 min) and m/z value (with a tolerance of 0.05 Da) indifferent samples were considered as the same ion. For
those peaks hard to be detected in the sample, the ion
intensities were documented as zero in the final data table.
Before submitted for multivariate analyses, the ion inten-
sities for each detected peak were normalized against
the sum of the peak intensities. The resulting three-
dimensional data comprising of peak number (tR-m/z
pair), sample name and ion intensity were analyzed by
OPLS-DA with the MarkerLynx software.
Results and discussion
Identification of SWDCF constituents by UPLC-QTOF-MS/
MS
The multiple chemical components in the SWDCF sam-
ples were identified and characterized by both negative and
positive ESI modes. The total current chromatograms at
the two modes were shown in Additional file 1: Figures S1-1
and 1-2. Diagnostic fragmentations were then checked by
MS/MS to confirm the results. Eighty-four constituents
were identified by comparing the tR, UVλmax, and MS
fragments characteristics of the compounds. The analyzed
and identified compounds were listed in Table 2. Among
these 84 compounds, there were ten organic acids, thirty
glycosides (monoterpene or iridoid glycosides or phenyl-
propanoids), fourteen lactones, eighteen flavonoids, and
eleven alkaloids.
Identification of phenolic acids
In this study, 10 phenolic acids were identified from
SWDCF samples according to the tR, UVλmax, and
MS fragment characteristics compared with reference
compounds and the literature [16,17]. They are gallic
acid (1), chlorogenic acid (2), caffeic acid (3), vanillic acid
(4), ferulic acid (5), isoferulic acid (6), protocatechuic
acid (7), coumaric acid (8), p-hydroxy benzoic acid (9),
and benzoic acid (10), respectively. TheMS characteristics
(Table 2) werem/z 169 [M - H]-,m/z 353 [M - H]-,m/z 179
[M - H]-,m/z 167 [M - H]-, m/z 193 [M - H]-,m/z 193 [M -
H]-, m/z 153 [M - H]-, m/z 163 [M-H]-, m/z 137 [M - H]-,
andm/z 121 [M -H]-, respectively.
Identification of monoterpene, iridoid and
phenylpropanoid glycosides
In the positive and negative MS experiments, there were
16 monoterpenes compounds with a pinane skeleton were
analyzed and identified (Table 2). These constituents come
from herbs of Paeoniae Radix Alba (in SWD, THSWD,
XFSWD, and QLSWD) and Paeoniae Radix Rubra (in
SFZYD). According to the MS/MS analysis of authentic
compounds, the major fragmentation mechanisms of
monoterpene glycosides were concluded. In the positive
MS experiments, all monoterpene glycosides were ionized
as sodiated molecules. The diagnostic ions of this type of
compounds were the loss of glucosyl group, aglycone
Table 2 Characterization of compounds in Siwu decoction categorized formulae by UPLC-QTOF-MS/MS
Peak
no.
TR (min) Positive ions (m/z) Negative ions (m/z) λmax (nm) Identification Origins
1 1.42 171 [M + H]+ 169 [M-H]-, 125 [M-HCOO]-, 97 [M-H-CO2-CO]
- 216, 270 Gallic acid A, B, C, D, E
2 3.07 355 [M + H]+, 377 [M + Na]+ 353 [M-H]-, 191[M-C9H7O3]
-, 179[M-C7H11O5]
-, 173 [M-C9H7O3-H2O]
- 326 Chlorogenic acid A, B, C, D, E
3 4.10 181 [M + H]+ 179 [M-H]-, 135 [M-HCOO]- 320, 240 Caffeic acid A, B, C, D, E
4 3.52 169 [M + H]+ 167 [M-H]-, 153 [M-CH3]
-, 137 [M-OCH3]
-, 123 [M-HCOO]- 290 Vanillic acid A, B, C, D, E
5 4.90 195 [M + H]+ 193 [M-H]-, 178 [M-H-CH3]
-, 149 [M-H-CO2]
-, 134 [M-HCOO]- 320 Ferulic acid A, B, C, D, E
6 8.90 195 [M + H]+ 193 [M-H]-, 237 [M-H + HCOO]-, 179 [M-CH3]
- 310 Isoferulic acid A, B, C, D, E
7 4.68 - 153 [M-H]-, 141 [M-H-CH3]
-, 109 [M-H-CO2]
- 310 Protocatechuic acid A, B, C, D, E
8 9.44 - 163 [M-H]-, 117 [M-H-HCOO]- Coumaric acid A, B
9 2.98 139 [M + H]+, 161 [M + Na]+ 137 [M-H]-, 119 [M-H-H2O]
- p-hydroxy benzoic acid A, B
10 7.02 - 121 [M-H]- 238, 272 Benzoic acid A, B
11 1.47 361 [M + H]+ 359 [M-H]-, 493 [M-H + HCOO]-, 405 [M + HCOO]-, 197 [M-H-glu]-, 179 [M-
H-glu-H2O]
-
210, 270 1-O-β-D- glucopyranosyl -
paeonisuffrone
A, B
12 1.51 517 [M + Na]+ 493 [M-H]-, 457 [M-H-2H2O]
-, 443 [M-H-2H2O- CH3]
-, 331 [M-2H-glu]-, 169
[M-sucrose]-
220, 270 10-O-galloylsucrose A
13 2.89 562 [M + Na]+, 383 [M + H-glu]+,








232 Paeoniflorin sulfonate A, B
14 3.85 481 [M + H]+, 319 [M + H - glu]+,
197 [M + H -glu-benzoyl]+, 161
[M + H -glu-benzoyl-2H2O]
+, 133
[M + H -glu-benzoyl-2H2O-CO]
+




233 Albiflorin A, B, C, D, E










16 5.84 481 [M + H]+, 503 [M + Na]+, 397,
319, 197






230 Paeoniflorin A, B, C, D, E
17 4.36 497 [M + H]+, 519 [M + Na]+, 381
[M + Na–pOHBA]+, 357 [M + Na–
Glc]+, 323 [M + Na–aglycone]+,






235, 322 Oxypaeoniflorin A
18 3.91 481 [M + H]+, 503 [M + Na]+ 479 [M-H]-, 525[M + HCOO]-, 449[M-CH2OH]
-, 327[M-benzoyl-CH2OH-OH]
- 220, 275 Isopaeoniflorin / albiflorin
R1
A
19 4.97 633 [M + H]+, 655 [M + Na]+, 153
[galloyl + H-H2O]
+
631[M-H]-, 525[M-benzoyl-2H]-, 449[M-galloy-HCHO]- 275 Galloylpaeoniflorin A, B
20 4.87 - 939 [M-H]-, 631 [M-2galloyl-3H]-, 469 [M- 2galloyl -3H-glu]- 220, 280 Pentagalloylglucose A, B,C



















Table 2 Characterization of compounds in Siwu decoction categorized formulae by UPLC-QTOF-MS/MS (Continued)
22 5.78 481[M + H]+, 319[M + H-glu]+, 197
[aglycone + H]+, 179[aglycone +
H-H2O]
+, 161[aglycone + H-2H2O]
+, 133[aglycone + H-2H2O-CO]
+
479[M-H]-, 463[M-OH]-, 341[M-benzoyl-2OH]- Mudanpioside I A, B






24 9.29 585[M + H]+, 607 [M + Na]+, 602
[M + H2O], 463[M + H-benzoyl]
+,
301[M + H-glu]+, 179[M + H-
benzoyl-glu]+, 151[M + H-
benzoyl-glu-CO]+
583[M-H]-, 629[M + HCOO]- 220, 270 Benzoylpaeoniflorin A, C
25 8.09 583[M-H]-, 629[M + HCOO]- 220, 270 Isobenzoylpaeoniflorin A, B
26 4.20 - 799[M-H]-, 637[M-caffeoyl]-, 525, 479, 449 cistanoside A or jionoside
A1/A2
A















28 2.75 729[M + Na]+ 705[M-H]-, 495, 443, 341, 271, 193 215 Isomaltopaeoniflorin
sulfonate
A
29 4.14 463[M + H]+, 484[M + Na]+, 498,
301, 179
461[M-H]-, 525, 479, 449, 327 232 decaffeoyl-verbascoside A
30 5.68 363[M + H]+, 385[M + Na]+, 340,
319, 197
361[M-H]-, 407[M + HCOO]-, 311, 287 232 6-O-β-D-glucopyranosyl
lactinolide
A
31 1.40 687 [M + H]+ 685[M-H]-, 731 [M-H + HCOO]-, 493 [M-H-glu- HCOO]- 215, 273 Rehmannioside D A, B
32 7.18 525 [M + H]+, 207 523[M-H]-, 569 [M + HCOO]-, 407, 341, 183 Melittoside A, B
33 3.71 - 785[M-H]-, 687[M-98]- 236, 279 Echinacoside A
34 4.55 435[M + HCOO]-, 389[M-H]-, 327[M-3CH3-H2O]
-, 178[M-C13H24O2]
- - Rehmaionoside A/B A, B
35 4.94 - 813[M-H]-, 515[M-C6H12O4-C9H10O2-H]
-, 469[M-glu-feruloyl]- Jionoside B1/B2 A, B
36 6.51 653[M + H]+ 651[M-H]-, 505[M-rhamnosyl-H]- 276 Martynoside isomer A
37 4.98 653[M + H]+ 651[M-H]-, 445[M-ferulic acid-2CH3]
-, 389[M-feruloyl-HCHO-3H2O-2H]
- 235, 322 Martynoside A
38 5.52 347[M + H]+ 345[M-H]-, 391[M + HCOO]-, 183[M-gku]-, 179[M-C10H15O2]
- - Rehmapicroside A,E
39 7.21 207[M + Na]+ 183[M-H]-, 165[M-H2O-H]
-, 139[M-HCOO]- - Rehmapicrogenin A,E
40 3.20 459[M + H]+, 325, 163 457[M-H]-, 323 215,237 Amygdalin B
41 6.09 249[M + Na]+, 227[M + H]+, 209
[M-H2O + H]




225[M-H]-, 195, 125 277 Senkyunolide J A, B, C, D,E




+, 165.0890 [M + H-
H2O-C3H6]
+
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43 6.61 225[M + H]+, 247[M + Na]+, 207
[M-H2O + H]




223[M-H]- 270 Senkyunolide H A, B, C, D, E
44 10.82 191[M + H]+, 173, 149, 135 189[M-H]-, 207[M-H + H2O]
- 295, 325 E-ligustilide A, B, C, D, E
45 13.74 191[M + H]+, 173, 149, 135 - 295, 325 Z-ligustilide A, B, C, D, E
46 9.44 381[M + H]+, 426[M + 2Na]+, 191
[C12H15O2]
+
- 280 Z-ligustilide dimmer E-232 A, B, C, D, E
47 13.62 381[M + H]+, 426[M + 2Na]+, 191
[C12H15O2]
+
- 296 Z,Z0-3,30,8,80-Diligustilide A, B, C, D
48 10.33 203[M + H]+, 225[M + Na]+ - - 3-butylidene-7-
hydroxyphthalide
A, B, C, D, E
49 8.04 189[M + H]+, 171[M-H2O + H]
+,
153[M-2H2O + H]
+, 117[M + 3H-
H2O-CO-C2H4]
+
187[M-H]- 260, 310 E-Butylideniphthalide A, B, C, D, E
50 9.31 189[M + H]+, 161[M-CO + H]+, 133
[M + H-CO-C2H4]
+
187[M-H]-, 205[M-H + H2O]
- 260, 310 Z-Butylidenephthalide A, B, C, D, E
51 12.90 381[M + H]+, 426[M + H + HCOO]
+, 236, 191
379[M-H]-, 424[M-H + HCOO]-, 397[M-H + H2O]
- 282 Angelicide A
52 13.65 381[M + H]+, 403[M + Na]+, 426
[M + 2Na]+, 191[C12H15O2]
+
379[M-H]-, 411 284 Riligustilide A
53 14.70 381[M + H]+, 403[M + Na]+, 191
[C12H15O2]
+
- 280 Tokinolide B A




379[M-H]-, 397[M-H + H2O]
- 230, 276 Levistolide A A, B, C, D, E
55 3.01 613[M + H]+, 635[M + Na]+, 451,
433, 163, 144
611[M-H]-, 543, 353, 191 227 Hydroxysafflor yellow A B
56 4.01 625[M + H]+, 593, 481, 433, 319,
301, 197
623[M-H]-, 611, 525, 479, 395 232 Isorhamnetin-3-O-
nehesperridin
B
57 2.56 803[M + H]+, 789, 627, 325 801[M-H]-, 787, 593, 515, 236 230, 269, 328 6-hydroxy-keampferol −3,
6-O-7-O-glucuronide
B
58 3.85 627[M + H]+, 481, 319, 197 625[M-H]-, 525, 479, 449 232 6- hydroxy-keampferol
−3, 6 – O – glucoside
B
59 5.13 595[M + H]+, 617[M + Na]+, 449,
287
593[M-H]-, 515, 449, 341, 193 241,265,330 Safflor yellow A B
60 7.29 303[M + H]+ 301[M-H]- 275 Queretin D
61 4.81 625[M + H]+, 317, 479 623[M-H]-, 525, 315 253, 351 Isohammetin-3-O-
neohesperidoside
D


















Table 2 Characterization of compounds in Siwu decoction categorized formulae by UPLC-QTOF-MS/MS (Continued)
63 4.40 771[M + H]+, 793[M + Na]+, 625
[M + H-rha]+, 479[M + H-2rha]+,
317[M + H-3rha]+
769[M-H]-, 525, 449, 327 253, 353 Typhaneoside D
64 12.10 287[M + H]+ 285[M-H]- 279 Keampferol D
65 5.64 317[M + H]+ 315[M-H]- 230, 273 Isohamnetin D
66 4.90 463[M + H]+, 352, 322 461[M-H]-, 285, 193 235, 323 Scutellarin E
67 6.33 447[M + H]+, 336, 352, 271 445[M-H]-, 891, 269 216, 277, 316 Baicalin E
68 7.48 461[M + H]+, 285 459[M-H]-, 919, 283 220, 273 Wogonoside E
69 8.83 271[M + H]+ 269[M-H]- 275, 322 Baicalein E
70 10.46 285[M + H]+ 283[M-H]-, 268[M-H-CH3]
- 274 Wogonin E
71 7.19 461[M + H]+, 285 459[M-H]-, 283, 175 271, 310 Oroxylin-A-glucuroside E
72 10.66 315, 373, 283 313[M-H]-, 375, 285 271 6-dimethoxy-wogonin E
73 0.64 136[M + H]+ 134[M-H]- Tetramethylpyrazine A, B, C, D, E




354[M-H]- 239, 297 Tetrahydropalmatin C, D, E
75 4.56 342[M + H]+, 311, 193, 179 - 237, 278 Tetrahydrocolumbamine C, D
76 5.71 354[M + H]+, 376[M + Na]+, 340,
320
352[M-H]- 238, 285 Protopine C, D
77 5.26 370[M + H]+, 356[M + H-CH2]
+,
327[M + H-CH3-CO]
+, 326[M + H-
CO2]
+
368[M-H]- 245, 330 Allocryptopine C, D, E
78 5.40 324[M + H]+, 338, 356 322[M-H]- - Tetrahydrocoptisine C, D, E
79 6.29 356[M + H]+, 207 354[M-H]- - Glaucine C, D, E
80 6.22 336[M + H]+, 207 354[M-H]- 277 Berberine C, D, E
81 6.48 366[M + H]+, 308 - 262, 332 Dehydrocorydaline C, D, E
82 5.78 368[M + H]+, 352[M + H-H2O]
+ 366[M-H]- 239, 277, 331 Corydaline C, D, E
83 6.52 339[M + H]+, 357[M + H + H2O]
+,
320[M-H2O]
337[M-H]- 237, 285 Jatrorrhizine C, E


















Figure 2 (See legend on next page.)
Figure 2 The intensity trend plots of sixteen representative
changed common components in SWDCF samples. X axis
represent for SWDCF samples (XF: XFSWD; TH: THSWD; SW: SWD; QL:
QLSWD; SF: SFZYD). Y axis represent for relative quantity of
target compounds.
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http://www.cmjournal.org/content/8/1/5group, benzoyl group, which lead to the occurrence of
ions at m/z 185, 219 or 121. Based on fragmentation
patterns, the compounds 14, 16, and 18 were identified
albiflorin, paeoniflorin, and isopaeoniflorin with MS
characteristics of m/z 481 [M+H]+, m/z 503 [M+Na]+,
and m/z 481 [M+H]+ by comparing to reference
compounds. And compound 18 had a typical ion of m/z
525 [M+HCOO]- at ES- mode.
Structures of compounds 17, 19, 22, 24 and 25 were
deduced from their characteristic UV and MS spectra and
fragmentation patterns. According to the literature [18-20],
compounds 17, 19 and 22 were tentatively identified as
oxypaeoniflorin, galloylpaeoniflorin and mudanpioside I,
respectively. The fragmentation patterns of compounds 24
and 25 were similar with those of monoterpene glycosides.
In the ESI-MS/MS experiment, the diagnostic ions of m/z
585 [M+H]+, m/z 463 [M+H - benzoyl]+, m/z 179 [M+
H – benzoyl - glu]+, m/z 151 [M+H - benzoyl – glu -CO]
+ at, and m/z 629 [M+HCOO]- at ES- mode. According
to the literature [17], the compound 24 (tR = 7.90 min), 25
(tR = 8.09 min) were tentatively identified as benzoylalbi-
florin, and isobenzoylpaeoniflorin, respectively.
Compounds 13, 15, 23, and 28 were identified as
sulfonates of monoterpene glycosides. Compound 13 was
C23H28O13S and had ions of m/z 495 [M-CH2OH-H2O]
-,
461 [M-SO2-H2O-H]
-, 341 [M-SO2-C7H5O- 2OH]
- and
243 [M-glu- benzoyl-H2O-CH3]
-. Compound 13 was
plausibly identified as paeoniflorin sulfonate [21]. With
the similar MS characteristics, compounds 15, 23, 28
were tentatively identified as galloylpaeoniflorin sulfonate,
benzoypaeoniflorin sulfonate, isomaltopaeoniflorin sulfon-
ate [18-20].
Compounds 11, 12, 20, 27 and 30 all exhibited
glucosyl group. According to the MS fragments and
UVλmax documented in the literature [22], compounds
11, 12, 20, 27 and 30 were tentatively identified as 1-O-β-
D- glucopyranosyl –paeonisuffrone, 10 -O -galloylsucrose,
pentagalloylglucose, isomaltopaeoniflorin or 60-O-β-D-
glucopyranosylalbiflorin, and 6-O-β-D-glucopyranosyl lacti-
nolide, respectively.
Three phenylpropanoid glycosides were detected and ten-
tatively assigned as acteoside/isoacteoside / forsythoside A
(21), cistanoside A or jionoside A1/A2 (26), decaffeoyl-
verbascoside (29) according to the literatures [21,23-25].
The MS spectrums were listed in Table 2.
The Rehmanniae Radix is rich sources of iridoid
glycosides [21,23-25]. At the positive and negative MS
experiments, 9 iridoid compounds were analyzed and
Figure 3 Typical HPLC-DAD chromatograms of mixed standards and samples. A: mixed standards; B: SWD; C: THSWD; D: XFSWD; E: SFZYD;
F: QLSWD (1. gallic acid, 2. protocatechuic acid,3. vanillic acid, 4. caffeic acid, 5. paeoniflorin, 6. ferulic acid, 7. senkyunolide I).
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Table 3 Calibration curves, LOD and LOQ data of investigated compounds by HPLC-DAD






Gallic acid Y = 2.4 × 106X-8022.9 0.9999 148.0-1480.0 7.5 14.1
Protocatechuic acid Y = 8.0 × 106X-36350 0.9994 38.4-384.0 8.6 19.2
Vanillic acid Y = 2.6 × 106X-18490 0.9997 32.0-320.0 5.0 10.0
Caffeic acid Y = 3.5 × 106X-25506 1.0000 35.6-356.0 6.5 13.6
Paeoniflorin Y = 1.1 × 106X + 160000 0.9990 476.0-4760.0 24.8 59.6
Ferulic acid Y = 1.1 × 107X-1.2 × 105 0.9997 136.0-1360.0 6.2 12.4
Senkyunolide I Y = 6.5 × 106X-9533.5 0.9999 46.0-460.0 6.3 12.6
a y is the logarithmic value of peak area and x is the logarithmic value of the reference compound’s concentration (μg/ml).
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http://www.cmjournal.org/content/8/1/5identified in SWDCF expcept SFZYD (Table 2). By com-
paring the tR, UVλmax and MS characteristics with
reference compounds and literature [23,26], they were
identified as rehmannioside D (31), melittoside (32),
echinacoside (33), rehmaionoside A/B (34), jionoside
B1/B2 (35), martynoside isomer (36), martynoside (37),
rehmapicroside (38), and rehmapicrogenin (39), respect-
ively. And amygdalin (40) was detected and identified in
THSWD.
Identification of lactones
Angelicae sinensis Radix and Chuanxiong Rhizoma are
rich sources of lactones or phthalide compounds
[16,26-28]. In the positive ion mode, 14 lactones were
analyzed and identified by comparing with reference
compounds and literature data [27,29]. Compounds 41,
42, and 43 were tentatively identified as senkyunolide J
(41), senkyunolide I (42), and senkyunolide H (43),
respectively.
Compounds 44, 45, 49 and 50 were isomers of
ligustilide and butylideniphthalide. The Z-Ligustilide and
Z-Butylidenephthalide were adopted as references, the
compounds 44 and 45 were isomers and identified as E-
ligustilide and Z- ligustilide with MS ion m/z 191 [M +
H]+; the compounds 49 and 50 were isomers and identi-
fied as E-Butylideniphthalide and Z-Butylidenephthalide







Gallic acid 1.75 1.78 1.81
Protocatechuic acid 0.76 1.21 3.16
Vanillic acid 1.31 1.55 1.79
Caffeic acid 0.98 0.97 2.27
Paeoniflorin 1.06 2.01 2.72
Ferulic acid 0.88 1.05 2.19
Senkyunolide I 1.16 1.12 2.22Six dimmer compounds were identified from SWDCF
possessing the same MS fragments ion m/z 381 [M+H]+.
According to the literature data [21,28,30], these com-
pounds were tentatively identified as Z-ligustilide dimmer
E-232 (46), Z, Z0-3,30,8,80-Diligustilide (47), angelicide
(51), riligustilide (52), tokinolide B (53), and levistolide A
(54), respectively.
Identification of flavonoids
Among 18 flavonoids identified from SWDCF, there were
eight flavonoid aglycones including quercetin (60),
isorhamnetin (65), keampferol (64), scutellarin (66), baicalein
(69), wogonin (70), 6-dimethoxy-wogonin (72), and
oroxylinA (71). The flavonoid glycosides were identified
by comparing the tR, UVλmax, and the MS fragments
characteristics to the standard substances.
Compounds 61, 62, and 63 contained fragment ion m/z
317 (Table 2). The MS/MS of m/z showed fragments in-
cluding m/z 287, 273, 153, and 123. These data were con-
sistent with those in the literatures [31,32]. The aglucone
was identified as isohamnetin. The three flavonoid glycosides
were identified as isohamnetin-3-O-neohesperidoside (61),
isohamnetin-3-O-rutinoside (62), and typhaneoside (63),
respectively.
Hydroxysafflor yellow A (55) and safflor yellow A (59)
were detected in THSWD from Carthami Flos. Com-
pound 59 possessed MS ions characteristics of m/z 595Repeatability (RSD,%; n = 6)
SFZYD XFSWD THSWD QLSWD
1.26 2.84 3.32 1.31
1.90 2.72 4.18 3.19
1.05 2.26 3.97 2.80
2.47 1.60 4.52 3.04
3.58 2.38 3.96 2.19
3.01 1.26 2.95 2.22
3.97 1.43 1.82 3.75
Table 5 Stability and recovery of seven analytes
Analytes Stability (RSD,%; n = 6) Recovery (%; n = 6)











Gallic acid 6.36 3.34 7.13 5.16 1.03 98.1 2.71 98.9 1.32 97.8 2.32 101.2 3.12 99.7 1.44
Protocatechuic acid 5.79 5.46 6.18 4.0 4.62 101.2 3.32 99.8 1.43 97.6 1.18 103.7 3.54 102.7 1.98
Vanillic acid 3.14 3.68 6.25 8.80 2.19 96.2 1.39 97.3 1.79 102.3 1.25 92.2 2.81 103.1 2.32
Caffeic acid 6.61 5.10 8.50 2.47 7.87 103.8 1.48 95.8 3.24 98.3 2.50 98.6 2.44 98.2 3.16
Paeoniflorin 6.13 3.79 7.37 8.36 4.07 97.1 3.25 98.2 2.77 95.4 1.15 94.0 1.36 95.8 2.17
Ferulic acid 4.54 3.74 1.31 7.65 2.10 99.7 1.22 103.2 1.94 99.3 1.43 97.5 2.65 104.6 1.89
Senkyunolide I 6.87 2.82 2.47 8.91 4.07 96.9 2.31 98.1 2.13 98.1 2.86 94.0 1.91 98.1 2.34
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http://www.cmjournal.org/content/8/1/5[M +H]+ and m/z 617[M +Na]+ at ES+ mode and m/z
593[M-H]- at ES- mode. Compound 55 had diagnostic
ions of m/z 613[M +H]+, and m/z 635[M +Na]+ at ES+
mode and m/z 611[M-H]- at ES- mode. Baicalin (67) and
wogonoside (68) were identified from QLSWD [33,34].Identification of alkaloids
The alkaloids compounds derived mainly from Chuanxiong
Rhizoma, Corydalis Rhizoma, and Coptidis Rhizoma. At the
positive ion mode, 11 alkaloids constituents were analyzed
and identified from SWDCF by comparing with reference
compounds and literature data [35]. Compound 74 with MS
characteristics ofm/z 356 [M+H]+, 338 [M+H-H2O]
+, and
312 [M+H-CO2]
+ was identified as tetrahydropalmatine
compared with the reference standard. Compounds 73, 76,
78, 80, 81, 82, and 83 were detected and identified from
XFSWD, SFZYD, and QLSWD as tetramethylpyrazine (73),
protopine (76), tetrahydrocoptisine (78), berberine (80),
dehydrocorydaline (81), corydaline (82), and jatrorrhizine
(83) by comparing with the reference standards, respectively.
The MS characteristics were m/z 136 [M+H]+, m/z 354
[M+H]+, m/z 324 [M+H]+, m/z 336 [M+H]+, m/z 366
[M+H]+,m/z 368 [M+H]+, andm/z 339 [M+H]+, respect-
ively. According to the literature [35], compounds 75, 77,Table 6 Contents of seven investigated compounds in
SWDCF
Analytes Contents of analyst (mean ± SD; n = 3; μg/g)
SWD THSWD XFSWD SFZYD QLSWD
Gallic acid 316.00 421.20 143.50 436.00 729.80
Protocatechuic acid 6.50 11.60 5.40 2.46 4.05
Vanillic acid 18.40 33.90 13.80 90.70 44.00
Caffeic acid 58.20 69.70 31.30 67.30 84.70
Paeoniflorin 2050.00 3430.00 790.00 3840.00 5140.00
Ferulic acid 120.00 166.70 81.30 225.70 310.70
Senkyunolide I 180.00 30.00 70.00 210.00 80.00and 79 were tentatively identified as tetrahydroco-
lumbamine, allocryptopine, and glaucine, respectively. The
MS characteristics ions were m/z 342 [M+H]+, m/z 370
[M+H]+, andm/z 356 [M+H]+, respectively. In addition, 5-
hydroxymethyl-2-furfural (5-HMF) (84) was identified from
SWDonly.
UPLC-Q-TOF-MS method was employed to identify
the constituents from SWDCF. In ESI-TOF-MS experi-
ment, accurate molecular mass of the components can be
obtained. As ESI was a soft ionization technique, the inter-
face produces little fragmentation of analytes and gene-
rally forms protonated molecular ions [M+H]+ for
positive ionization mode or [M-H]- for negative ionization
mode. Comparing the mass spectra of the compounds
with the standards and those in the literature, the com-
mon and different components were unequivocally identi-
fied from every formula of SWDCF. These data would be
provided the bioactive components for activities of differ-
ent formulae.
The markers obtained by MarkerLynx™
The principal components analysis (PCA) was done by
the Waters MarkerLynx™ software. In this study, SWD,
THSWD, XFSWD, SFZYD and QLSWD were injected six
times each in two ESI modes. Unsupervised PCA was
performed to globally evaluate the chemical consistency
among these five SWDCF decoctions. The data from both
positive and negative ion modes were displayed as scores
plots (Additional file 1: Figures S2-1 and 2-2). The scores
plots demonstrated a clear classification trend among
SWDCF samples, with all the observations falling within
the Hotelling T2 (0.95) ellipse, which confirmed the fact
that chemical difference exists among SWDCF. The
results showed that the SFZYD and QLSWD were signifi-
cantly different to SWD, THSWD, and XFSWD, while
SWD, THSWD, and XFSWD were close to each other.
These data indicated that the chemical composition and
quantity of components changed after combining SWD
with different herbs.
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http://www.cmjournal.org/content/8/1/5Chemical markers were analyzed to find out the changed
common components contributing most to the SWDCF.
Figures 2 showed the representative mass spectra of sixteen
common and the greatest change compounds. According
to the intensity trends of fragment ions from five decoc-
tions samples, the intensity of the common chemical
markers (paeoniflorin 16, albiflorin 14, ferulic acid 5,
isoferulic acid 6, senkyunolide I 42, 3-butylidene-7-
hydroxyphthalide 48, levistolide A 54, tetramethylpyrazine
73, E-Butylideniphthalide 49, Z-Butylidenephthalide 50, Z-
ligustilide 45, E-ligustilide 44, Z-ligustilide dimmer 46,
gallic acid 1, chlorogenic acid 2, benzoylpaeoniflorin 24)
were different in every formula of SWDCF.
The peak areas of components 16 (tR 5.80 min, m/z
481.1750), 14 (tR 3.90 min, m/z 481.1710), 42 (tR 6.26 min,
m/z 225.1144), 54 (tR 12.60 min, m/z 399.2193), 73
(tR 0.64 min,m/z 136.0622), 49 (tR 8.08 min,m/z 189.0919),
50 (tR 9.27 min, m/z 189.0919), 46 (tR 13.80 min, m/z
191.1049), 45 (tR 10.82 min,m/z 191.1079), 44 (tR 9.44 min,
m/z 191.1073) were higher in SWD than other formulae.
XFSWD possessed greater peak area of compound 2 and 5,
while SFZYD possessed high content of compound 6.Optimization of the HPLC conditions
A small amount of acid was added into the mobile phase
which could inhibit the ionization of these components
to improve the peak shape and restrain the peak tailing
due to the existence of acidic ingredients in SWDCF
samples. 0%, 0.1% and 0.2% aqueous formic acid and
acetic acid solutions were compared. The results showed
that 7 compounds could be baseline separated when
0.1% aqueous formic acid solution was selected.
DAD detection was set at the wavelength range of
190–400 nm. For the satisfactory sensitivity, resolution
and lower noise, four wavelengths at 230 nm, 260 nm,
277 nm, and 320 nm were selected for determining the
different compounds in SWDCF. According to absorp-
tion curve of the tested analytes, the paeoniflorin had
optimal sensitivity for detection at 230 nm, 320 nm for
ferulic acid, 260 nm for gallic acid, vanillic acid, and
caffeic acid, and 277 nm for senkyunolide I. Thus, a
switching UV wavelength method was established by a
variable-wavelength spectrophotometric detector. Under
the optimized HPLC-UV conditions, the investigated
analytes were well separated and detected in 85 min
(Figure 3).
Prior to sample analysis the optimal process of extrac-
tion had to be investigated. According to the applied
form of decoction, the SWDCF were extracted by
refluxing with water for twice. Ethanol (95%) was added
to the filtrates until the concentration of ethanol was
adjusted to 50% and seven compounds were almost
completely extracted.Validation of the quantitative analysis
The HPLC–DAD method for quantitation analysis was
validated to determine the linearity, LOD, and LOQ. Good
linear correlation and high sensitivity at these chromato-
graphic conditions were confirmed by the correlation
coefficients r2 > 0.9990 and P = 3.7501 × 10-9, 1.3503 × 10-7,
3.7553 × 10-8, 0, 3.7513 × 10-7, 3.7553 × 10-8, 3.7501 × 10-9
for gallic acid, protocatechuic acid, vanillic acid, caffeic acid,
paeoniflorin, ferulic acid, senkyunolide I, respectively,
within the test ranges, and the overall LODs and LOQs
were in the range of 5.0–24.8 and 10.0–59.6 μg/mL, re-
spectively (Table 3).
As shown in Table 4, the intra- and inter-day precisions,
repeatability and stability of the seven analytes were less
than 3%. The overall recoveries lay between 92.20% and
104.60% with RSD less than 3.54% for seven components
in all samples. These results indicated that the HPLC fin-
gerprint chromatograms had a good repeatability, preci-
sion, accuracy, and recovery (Tables 4 and 5) and the
developed HPLC-DAD method was a reliable and useful
method for assessment of SWDCF.
Sample analysis
The HPLC-DAD method was then subsequently applied
to simultaneously determine the chemical markers includ-
ing gallic acid, protocatechuic acid, vanillic acid, caffeic
acid, paeoniflorin, ferulic acid, senkyunolide I in SWDCF
samples. The results (Table 6) showed there were remark-
able differences among the contents of the chemical
markers analyzed in different samples. Paeoniflorin (5)
was found to be a predominant constituent in both of
QLSWD and SFZYD, while the lowest contents in SWD
except XFSWD, suggesting that the active compounds of
paeoniflorin was dissolved increasedly after the SWD
combined with other herbs. The contents of senkyunolide
I in SWDCF were decreased except SFZYD varing from
31.30 to 84.70 mg/g. The phenolic acids including gallic
acid, caffeic acid, ferulic acid, vanillic acid, and proto-
catechuic acid were increased significantly except in
XFSWD.
Conclusion
The chemical profiles with 84 components in SWDCF, in-
cluding monoterpene glycosides, acetophenones, galloyl
glucoses, even some isomers in the complex system were
characterized by UPLC–QTOF–MS/MS.Additional file
Additional file 1: Figure S1. Typical BPI chromatogram of SWDCF (A)
SWD, (B) THSWD, (C) XFSWD, (D) SFZYD, and (E) QLSWD. Figure S1-1 ESI+;
Figure S1-2 ESI. Figure S2: PCA model results between SWDCF samples.
(A, ESI+; B, ESI-).
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SWDCF: Siwu decoction categorized formulae; UPLC - QTOF - MS /MS: Ultra-
high performance liquid chromatography coupled with time-of-flight mass
spectrometry; CM: Chinese medicine; CF: Categorized formulae; SWD: Siwu
decoction; THSWD: Taohong Siwu decoction; PD: Primary dysmenorrheal;
XFSWD: Xiangfu Siwu decoction; SFZYD: Shaofu Zhuyu decoction;
QLSWD: Qinlian Siwu decoction; ESI: Electrospray ionization.
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